Please describe your proposed solution.

Our proposed solution aims to address the pressing issue faced by individuals with diabetes and metabolic syndrome by harnessing the power of nature and sustainable practices. We will create Low Molecular Weight Inhibitors concentrates from two potent sources: Green Tea and Blueberries, employing innovative and environmentally friendly green chemistry procedures.

Our approach is rooted in scientific evidence that demonstrates the potential of Low Molecular Weight Inhibitors to mitigate the effects of diabetes and metabolic syndrome. By formulating these natural food supplements, we aim to provide individuals suffering from these conditions with a reliable and effective means to enhance their overall well-being.

What sets our solution apart is its holistic approach that combines scientific excellence, sustainability, and social impact. By producing the Low Molecular Weight Inhibitors concentrates, we will enable patients to access a natural remedy that can potentially alleviate the symptoms and complications associated with diabetes and metabolic syndrome.

To ensure widespread access and real-life impact, we will donate the final product in the form of veggie-gello capsules to hospitals, doctors specializing in diabetes care, and hospice facilities. This approach will directly engage medical professionals and healthcare institutions, allowing us to reach a large and diverse group of patients who will benefit from our product.

Our solution aligns perfectly with the vision and principles of Cardano. By leveraging blockchain technology, specifically the Cardano blockchain, we can demonstrate transparency, traceability, and immutability in the entire process — from production to donation. This ensures accountability and safeguards the integrity of our mission. Cardano's emphasis on sustainability and its commitment to providing real-life solutions makes our project an ideal fit for funding, as it represents the positive impact that blockchain-based solutions can have on society.

By supporting our project, Cardano will not only contribute to improving the quality of life for individuals with diabetes and metabolic syndrome but also showcase the tangible benefits that blockchain technology can bring to the healthcare sector. Together, we can create a lasting and meaningful impact, making a difference in the lives of patients and advancing the broader goals of Cardano's ecosystem.

How does your proposed solution address the challenge and what benefits will this bring to the Cardano ecosystem?

It generates physical solutions for a worldwide problem (Diabetes & metabolic syndrome) in a sustainable fashion while directly impacting the quality of life and health of the population in urban and rural areas, where diabetes and metabollic syndrome is rising rapidly. At the same time it generates a huge amount of visibility for the network. We will accompany all our work with extensive publicity about Cardano and blockchain, contacting local media and authorities and gathering with them and the community at live events, where we will teach about blockchain, Cardano, project Catalyst and the scientific developments behind our solution.

Our proposed solution directly addresses the aims outlined in the Challenge by contributing to the growth and enrichment of the Cardano ecosystem. By creating Low Molecular Weight Inhibitors concentrates from sustainable sources and using green chemistry principles, our project aligns with the overarching goals of sustainability and innovation that Cardano advocates.

The impact of our project goes beyond the immediate funding for the project team. It brings significant value to the Cardano ecosystem in multiple ways:

1. Enriching the Product & Integrations Category: Our project falls within the Product & Integrations category, which aims to foster the development of diverse products and integrations that enhance the Cardano community's experience. By providing a natural food supplement specifically designed for individuals with diabetes and metabolic syndrome, we introduce a unique and valuable product to the ecosystem. This offering not only addresses a key health concern but also promotes the adoption of Cardano as the preferred platform for health-related solutions, giving Cardano and Catalyst visibility to patients, healthcare providers, scientific researchers and government authorities. At the same time, the Products and Integrations category is known for hosting mostly code-based solution, with little to no real-word physical solutions being historically funded.
2. Community Engagement and Adoption: Our project has the potential to attract new users and engage a broader audience within the Cardano community. By offering a solution that directly improves the quality of life for individuals with diabetes and metabolic syndrome, we create a compelling reason for people to interact with the Cardano blockchain. The positive impact and tangible benefits experienced by users will foster greater adoption, feedback, and further innovation within the ecosystem. It promotes the adoption of Cardano as the preferred platform for health-related solutions, giving Cardano and Catalyst visibility to patients, healthcare providers, scientific researchers and government authorities
3. Social Impact: The successful implementation of our project will have a meaningful and tangible impact on the lives of patients with diabetes and metabolic syndrome. By providing them with a natural food supplement that can mitigate the effects of these conditions, we empower individuals to take control of their health and well-being. This positive change not only improves their quality of life but also showcases the transformative potential of Cardano-powered solutions in the healthcare sector, promoting the adoption of Cardano as the preferred platform for health-related solutions, giving Cardano and Catalyst visibility to patients, healthcare providers, scientific researchers and government authorities

Quantifying the exact impact of our project within a specific timeframe is challenging, but we anticipate the following outcomes:

a. Increased User Engagement: We aim to attract a substantial number of users within the Cardano community who will benefit from and interact with our natural food supplement solution. We anticipate a significant uptake of our product, resulting in a notable increase in usage and transactions within a reasonable timeframe.

b. Community Growth: Through our outreach efforts, we expect to expand the Cardano community by attracting individuals who are interested in health-related solutions and are seeking alternatives to traditional approaches. By fostering a community of like-minded individuals, we contribute to the overall strength and diversity of the Cardano ecosystem.

c. Inspiration for Future Innovations: Our project serves as a catalyst for further innovation within the Cardano ecosystem. By showcasing the potential of blockchain-based solutions in addressing real-world health challenges, we inspire and encourage other entrepreneurs and developers to explore novel applications of Cardano technology.

Overall, our project offers a compelling solution that not only addresses a pressing health issue but also brings real value to the Cardano ecosystem. By supporting our project, funders can actively contribute to the growth and sustainability of Cardano while making a positive impact on the lives of individuals affected by diabetes and metabolic syndrome.

How do you intend to measure the success of your project?

As a main output metrics we will have:

1. The production of at least 150 kg of Low Molecular Weight inhibitors concentrate from a sustainable source based on green chemistry principles.
2. Production and donation of at least 750 packages of "Catalyst Gluc", each package containing 180 capsules of 0.5g each to local healthcare providers (considering a daily dose of 2 capsules before each meal, 3 times a day)
3. At least 2 live events with press coverage and Cardano & Catalyst visibility.

Please describe your plans to share the outputs and results of your project?

We have comprehensive plans in place to effectively share the outputs and results of our project, ensuring widespread dissemination and long-term impact within the Cardano ecosystem and beyond.

1. Knowledge Sharing and Accessibility: Throughout the project, we will prioritize knowledge sharing by making the findings of our extensive scientific literature review publicly accessible. This will involve publishing the literature review and related research papers on reputable platforms and journals, maximizing the reach of our work. Additionally, we will collaborate with relevant academic institutions, research centers, and industry conferences to present our findings and insights, facilitating further discussion and engagement.
2. Live Events and Stakeholder Engagement: We will organize two live events in collaboration with the partnering research center, local government authorities, and stakeholders. These events will serve as platforms to communicate the project's objectives, progress, and outcomes. By inviting local government authorities, medical professionals, and the broader community, we aim to maximize awareness and engagement. These events will also provide opportunities for networking, collaboration, and potential partnerships for future projects.
3. Media Coverage and Public Relations: We recognize the importance of media coverage in amplifying our message and reaching a wider audience. To achieve this, we will actively engage with journalists, press releases, and media outlets to ensure comprehensive coverage of our project. By showcasing the positive impact of sustainable low molecular weight inhibitors and highlighting the role of Cardano blockchain and Catalyst in driving innovation, we will generate interest and attract attention from various sectors.
4. Online Channels and Digital Presence: We will leverage online channels and establish a strong digital presence to share the outputs, impact, and opportunities arising from our completed project. This will include maintaining an informative project website, engaging with social media platforms, and actively participating in relevant online communities and forums. Through regular updates, blog posts, and interactive content, we will ensure continuous engagement with our stakeholders, including the Cardano community, researchers, healthcare professionals, and potential users.

Regarding the results generated from the project, we anticipate utilizing them in further research and development activities to foster continuous improvement and innovation. These include:

1. Iterative Improvements: By closely monitoring the quality assurance checks and feedback from the testing phase, we will identify areas for improvement in the extraction and production processes. The results will guide us in refining our methodologies, enhancing the product's quality, and ensuring its effectiveness. We will document these improvements and share them with the Cardano community and relevant stakeholders, encouraging further collaboration and knowledge exchange.
2. Future Research Projects: The outcomes of our project will provide valuable insights and data that can be utilized in future research endeavors. We anticipate that our work will contribute to a growing body of knowledge on sustainable low molecular weight inhibitors for diabetes and metabolic syndrome. These findings can inform and inspire researchers, scientists, and developers to explore related areas, expanding the boundaries of innovation within the Cardano ecosystem.
3. Collaboration Opportunities: The project's results will open doors for potential collaborations and partnerships with organizations, research institutions, and healthcare professionals. By sharing the outputs and impact, we aim to attract like-minded individuals and entities interested in advancing the field of sustainable healthcare solutions. Collaboration may involve joint research initiatives, pilot programs, or commercialization efforts, further leveraging the results generated from our project.

In summary, our plans encompass a multi-faceted approach to sharing the outputs and results of our project. Through live events, media coverage, online channels, and engagement with various stakeholders, we aim to maximize the dissemination of knowledge, create awareness, and foster collaboration. Additionally, we anticipate utilizing the results to drive further research, iterative improvements, and potential partnerships that will contribute to the continued development of sustainable solutions within the Cardano ecosystem.

What is your capability to deliver your project with high levels of trust and accountability?

Green Pro Technology is a chilean sustainable technology company that has already created highly valuable nutraceutics based on scientific evidence (https://linktr.ee/greenprotech).

-Millaray Hernandez Millan the CEO is a top-tier Chemist with vast experience in the enviromental and food sector, currently studying an MBA and a strong female entrepreneur who also practices swordmanship and archery. She always makes sure everything is right on track and leads the team very effectively.

-Andres Halabi Díaz the CTO is a top tier chemist, currently studying a PHD in Molecular Physical chemistry, with vast experience in artificial intelligence, predictive models, green chemistry and blockchain. He is in charge of all the formulations of our products and all the scientific research backing up their efficacy.

-Alfredo Eloy the CMO, has lots of experience in leading marketing, communications and direction of companies, he will ensure our efforts are properly align and get the best exposure for Cardano and project Catalyst.

-Ignacia Muñoz the CDO, with a degree in bussiness engenieering and strong experience with digital marketing and blockchain, she will maintain an entertaining and engaging appeal on digital media, with a focus on redirecting people to Cardano and Catalyst

What are the main goals for the project and how will you validate if your approach is feasible?

The main goals of the project, "Low Molecular Weight sustainable nutraceutics for diabetes mellitus and metabolic syndrome," are to develop a sustainable solution to address the challenges of diabetes and metabolic syndrome and improve the quality of life for affected individuals. The project aims to create a concentrated extract of Low Molecular Weight Inhibitors (LMWI) from green tea and blueberries using sustainable and green chemistry procedures.

To validate the feasibility of the approach, the following steps can be taken:

1. Conduct a comprehensive literature review: Evaluate existing scientific research and studies on the effectiveness and safety of Low Molecular Weight Inhibitors in lowering blood glucose levels in humans. This will provide a foundation for the project's approach. This extensive literature research will be fully open and uploaded to the Cardano blockchain.
2. Formulate and optimize the extraction process: Work closely with researchers and experts to develop a sustainable and efficient extraction process for obtaining the Low Molecular Weight Inhibitors from green tea and blueberries. This process should adhere to green chemistry principles.
3. Conduct laboratory tests: Perform laboratory tests to analyze the composition, purity, and concentration of the extracted Low Molecular Weight Inhibitors. This will help ensure the quality and efficacy of the final product.
4. Monitor and evaluate outcomes: Continuously monitor the progress and outcomes of the project, including the results of our literature review, new approaches developed by the team and events realized by the team. Analyze data, collect feedback from participants and healthcare professionals, and make any necessary adjustments to optimize the approach.

By following these steps and ensuring rigorous scientific evaluation, the project team can validate the feasibility of their approach in developing sustainable nutraceutics for diabetes mellitus and metabolic syndrome.

Please provide a detailed breakdown of your project’s milestones and each of the main tasks or activities to reach the milestone plus the expected timeline for the delivery.

Milestone 1: Scientific Literature Review and Machinery Acquisition

Months 1-3:

1. Conduct an extensive scientific literature review on sustainable low molecular weight inhibitors derived from plant sources for diabetes and metabolic syndrome. Make the findings publicly accessible to promote knowledge sharing.
2. Formulate an optimized extraction process for obtaining the low molecular weight inhibitors. This process should be based on the insights gathered from the literature review.
3. Identify and evaluate the required machinery for the extraction and drying of the plant extracts. Perform a market analysis to ensure the machinery meets the project's needs in terms of quality, efficiency, and sustainability.
4. Purchase the selected machinery and ensure its delivery order to the project's designated location.

Milestone 2: Machinery Setup, Production, and Branding

Months 4-9:

1. Install and set up the acquired machinery at the partnering research center, ensuring it is fully operational and meets safety standards.
2. Collaborate with the partnering research center to organize a live event that highlights the project's objectives, introduces Cardano and Catalyst, and emphasizes the importance of sustainable low molecular weight inhibitors for diabetes and metabolic syndrome. Invite local government authorities and stakeholders to participate.
3. Produce low molecular weight inhibitor extracts from sustainable plant sources using the established extraction process (e.g., ethanol/water extractions and spray drying). Monitor the production process for quality control.
4. Design and create appropriate packaging for the low molecular weight inhibitor extracts. Include the branding "Catalyst Gluc" and ensure all required labels, including Cardano and Catalyst logos, are prominently displayed.

Milestone 3: Quality Assurance and Testing

Months 10:

1. Conduct rigorous quality assurance checks on the produced low molecular weight inhibitor extracts. Implement testing protocols to assess their efficacy, purity, and safety.
2. Continuously refine the extraction and production processes based on feedback from quality assurance testing. Make any necessary adjustments to optimize the product's quality and effectiveness.

Milestone 4: Donation Planning and Execution

Months 11:

1. Collaborate with the partnering research center, local government authorities, and relevant organizations to identify target families, medical professionals, hospitals, or caring facilities in need of the low molecular weight inhibitor extracts.
2. Plan and organize a donation campaign in which the product is distributed to the identified beneficiaries on behalf of Green ProTechnology, Cardano blockchain, and Project Catalyst. Ensure the donations are recorded and stamped as NFTs on the Cardano blockchain to provide permanent proof and transparency.
3. Document the donation process and capture the impact through photographs, videos, and testimonials from recipients. These materials will be utilized for future reporting and promotion.

Milestone 5: Project Wrap-up and Final Reporting

Month 12:

1. Organize a final live event with the partnering research center and local government authorities to share the project's achievements and impact. Emphasize the successful utilization of Cardano blockchain and Catalyst in the project's execution and transparency.
2. Prepare a comprehensive final report documenting the project's journey, outcomes, challenges, and lessons learned. Include an analysis of the monthly reports and milestones submitted to the Catalyst team.
3. Upload all relevant documentation, including live event recordings, proofs of accomplishment, monthly reports, and the final report, as NFTs on the Cardano blockchain for permanent storage and public access.

All live events and all proofs of accomplishment will be uploaded directly to the Cardano blockchain as NFTs where they will remain as permanent proof for future generations to come. All monthly reports and milestones submitted to the Catalyst team will also be open for the public to analyze and comment.

Please describe the deliverables, outputs and intended outcomes of each milestone.

Milestone 1: Scientific Literature Review and Machinery Acquisition

<u>Deliverables and Outputs:</u>

1. Comprehensive scientific literature review on sustainable low molecular weight inhibitors for diabetes and metabolic syndrome.
2. Formulated extraction process documentation detailing the optimized method.
3. Market analysis report on the required machinery for extraction and drying.
4. Purchased machinery and confirmation of delivery to the project location.

<u>Intended Outcomes:</u>

1. Increased understanding of sustainable low molecular weight inhibitors from plant sources for diabetes and metabolic syndrome.
2. Established and documented extraction process that serves as a foundation for further stages.
3. Identification and acquisition of appropriate machinery for the extraction and drying process.
4. Preparation for the setup and implementation of the machinery in the following milestones.

<u>Measurement Criteria:</u>

1. Number of scientific papers reviewed and documented in the literature review.
2. Completion and documentation of the extraction process formulation.
3. Market analysis report indicating the identified machinery options.
4. Confirmation of machinery purchase and successful delivery.

Milestone 2: Machinery Setup, Production, and Branding

<u>Deliverables and Outputs:</u>

1. Installed and operational machinery for extraction and drying at the partnering research center.
2. Organized live event with participating research center, local government authorities, and media coverage.
3. Produced low molecular weight inhibitor extracts from sustainable plant sources.
4. Branded packaging with the name "Catalyst Gluc" and all required labels, including Cardano and Catalyst logos, together with extra information on both Cardano, Catalyst and this project.

<u>Intended Outcomes:</u>

1. Successful setup and functioning of the machinery at the designated research center.
2. Increased awareness of the project, Cardano, Catalyst, and the importance of sustainable low molecular weight inhibitors through the live event and media coverage.
3. Production of high-quality low molecular weight inhibitor extracts.
4. Professional and visually appealing packaging that enhances the product's marketability and brand recognition, together with information about Cardano, Project Catalyst and this project in particular.

<u>Measurement Criteria:</u>

1. Confirmation of the installed and fully operational machinery.
2. Event documentation, including photos, videos, and media coverage.
3. Quantity and quality of low molecular weight inhibitor extracts produced.
4. Packaging design and branding elements finalized and implemented.

Milestone 3: Quality Assurance and Testing

<u>Deliverables and Outputs:</u>

1. Comprehensive quality assurance documentation outlining the testing protocols and results.
2. Organized live event with research center, authorities, and media coverage.
3. Improved extraction and production processes based on quality assurance feedback.

<u>Intended Outcomes:</u>

1. Assurance of the product's efficacy, purity, and safety through rigorous quality assurance and testing.
2. Continual refinement of the extraction and production processes to optimize the product's quality and effectiveness.
3. Increased awareness and visibility of the project, Cardano, Catalyst, and the commitment to quality through the live event and media coverage.

<u>Measurement Criteria:</u>

1. Quality assurance documentation completed, including test protocols, results, and adherence to standards.
2. Event documentation and media coverage of the live event.
3. Iterations and improvements made to the extraction and production processes based on quality assurance feedback.

Milestone 4: Donation Planning and Execution

<u>Deliverables and Outputs:</u>

1. Collaboration documentation with research center, authorities, and organizations for identifying beneficiaries and planning the donation campaign.
2. Donated low molecular weight inhibitor extracts to target families, medical professionals, hospitals, or caring facilities.
3. Recorded and stamped NFTs on the Cardano blockchain for all donations made.

<u>Intended Outcomes:</u>

1. Successful identification of beneficiaries in need of the low molecular weight inhibitor extracts.
2. Execution of a well-planned donation campaign that delivers the product to the intended recipients.
3. Transparent and permanent proof of the donations through NFTs on the Cardano blockchain.
4. Recognition of Green ProTechnology, Cardano blockchain, and Project Catalyst for their contribution to the donations.

<u>Measurement Criteria:</u>

1. Collaboration documentation confirming the identification of beneficiaries and the planning of the donation campaign.
2. Documentation of the donated low molecular weight inhibitor extracts and their delivery to the target recipients.
3. Creation and storage of NFTs on the Cardano blockchain as permanent proof of the donations.
4. Acknowledgment and recognition received for the project's contributions to the community.

Milestone 5: Project Wrap-up and Final Reporting

<u>Deliverables and Outputs:</u>

1. Final report summarizing the project's journey, outcomes, challenges, and lessons learned.
2. Uploading of all relevant project documentation, live event recordings, proofs of accomplishment, monthly reports, and the final report as NFTs on the Cardano blockchain.

<u>Intended Outcomes:</u>

1. Comprehensive documentation of the project's progress, achievements, and key insights gained throughout its execution.
2. Permanent storage and accessibility of project documentation through NFTs on the Cardano blockchain for future reference and analysis.

<u>Measurement Criteria:</u>

1. Completion and submission of the final report covering all essential aspects of the project.
2. Uploading of project documentation, live event recordings, proofs of accomplishment, monthly reports, and the final report as NFTs on the Cardano blockchain.

To track the project's progress, the following measurement criteria will be used across the milestones:

1. Completion and documentation of specific deliverables and outputs within each milestone.
2. Adherence to the project timeline and milestones with corresponding reports.
3. Feedback and evaluation from collaborating partners, research center, authorities, and/or beneficiaries.
4. Documentation and media coverage of live events, including attendance, engagement, and impact.
5. Monitoring and assessment of the quality, efficacy, and safety of the low molecular weight inhibitor extracts through rigorous testing and quality assurance protocols.
6. Confirmation of the successful setup, operation, and utilization of the machinery for extraction and production.
7. Number and impact of donations made to target families, medical professionals, hospitals, or caring facilities.
8. Documentation and recognition received from stakeholders, the public, and the community for the project's contributions and accomplishments.

By regularly measuring and assessing these factors, the project team can effectively track the progress and success of the project's implementation.

Please provide a detailed budget breakdown of the proposed work and resources.

Milestone 1: Scientific Literature Review and Machinery Acquisition (Month 1-3) –> ₳150.000

1. Scientific Literature Review (₳ 12.000):

• Cost: Researcher/staff salaries or external consultants for literature review and analysis.

2. Formulated Extraction Process Documentation (₳ 12.000):

• Cost: Researcher/staff salaries for formulating the extraction process.

3. Market Analysis for Machinery (₳ 8.000):

• Cost: Researcher/staff salaries or external consultants for conducting the market analysis.

4. Machinery Acquisition (₳ 120.000):

• Cost: Purchase or lease cost of the required machinery for extraction and drying.

Milestone 2: Machinery Setup, Production, and Branding (Month 4-9) –> ₳ 32.000

1. Machinery Setup (₳ 13.000) :

• Cost: Installation, setup, and commissioning of the machinery at the partnering research center, including any necessary modifications or infrastructure requirements.

2. Live Event and Media Coverage (₳ 10.000):

• Cost: Venue rental, event organization, publicity, media coverage, equipment for presentations, and related expenses.

3. Production of Low Molecular Weight Inhibitor Extracts (₳ 7.000):

• Cost: Raw materials (plant sources), utilities (water, ethanol), lab supplies, and operational expenses for extraction and spray drying processes.

4. Packaging and Branding (₳ 2.000):

• Cost: Design and production of branded packaging, labels, and required printing services.

Milestone 3: Quality Assurance and Testing (Month 10) –> ₳20.000

1. Quality Assurance Documentation (₳ 10.000)

• Cost: Researcher/staff salaries or external consultants for developing quality assurance protocols and documentation.

2. Media Coverage (₳ 10.000):

• Cost: Publicity, media coverage, marketing.

3. Process Refinement:

• Cost: Researcher/staff salaries or external consultants for process optimization based on quality assurance feedback.

Milestone 4: Donation Planning and Execution (Month 11)–> ₳17.200

1. Collaboration Documentation (₳ 2.200):

• Cost: Researcher/staff salaries or external consultants for coordination with research center, authorities, and organizations involved in identifying beneficiaries and planning the donation campaign.

2. Donations (₳ 5.000):

• Cost: Donation, logistics and transportation expenses, and any associated legal and regulatory requirements.

3. Live Event and Media Coverage, to be executed in month 12 but requires prior planning (₳ 10.000):

• Cost: Venue rental, event organization, publicity, media coverage, equipment for presentations, and related expenses.

Milestone 5: Project Wrap-up and Final Reporting (Month 12)

1. Final Report:

• Cost: Researcher/staff salaries or external consultants for preparing a comprehensive final report documenting the project's outcomes, learnings, and recommendations.

2. Documentation and NFTs:

• Cost: Uploading project documentation, live event recordings, proofs of accomplishment, monthly reports, and the final report as NFTs on the Cardano blockchain.

3. Live Event and Media Coverage, to be executed in month 12 but requires prior planning:

• Cost: Venue rental, event organization, publicity, media coverage, equipment for presentations, and related expenses, should all be covered from Milestone 4, now would just require the execution.

Additional Budget Elements across the whole project –> ₳180.800:

1. Publicity/Marketing/Promotion/Community Engagement (₳ 20.000):

• Cost: Advertising, promotional materials, community engagement activities, social media campaigns, and related expenses.

2. Project Management and General Execution (₳ 13.400 monthly):

• Cost: Salaries for project managers (CEO, CTO, CMO and CDO), and/or executives and external consultants responsible for overseeing and coordinating the project's activities.

Who is in the project team and what are their roles?

Our project team for the "Low Molecular Weight Inhibitors as sustainable nutraceutics for blood glucose regulation in diabetes mellitus and metabolic syndrome., powered by Cardano and Catalyst" initiative consists of highly qualified individuals with expertise in various areas relevant to the project's objectives. Here are the team members and their respective roles:

1. Millaray Hernandez Millan (CEO) - LinkedIn: Millaray Hernandez Millan Millaray is a top-tier Chemist with extensive experience in the environmental and food sectors. As the CEO, she oversees the overall management of the project, ensures its progress, and leads the team effectively. Her expertise in sustainable technology and entrepreneurship contributes to the project's success.
2. Andres Halabi Díaz (CTO) - LinkedIn: Andres Halabi Díaz Andres is a highly skilled chemist currently pursuing a Ph.D. in Molecular Physical Chemistry. He specializes in artificial intelligence, predictive models, green chemistry, and blockchain technology. As the CTO, he is responsible for formulating the extracts, conducting scientific research, and implementing blockchain solutions for transparency and traceability.
3. Alfredo Eloy (CMO) - LinkedIn: Alfredo Eloy Alfredo brings extensive experience in leading marketing, communications, and company direction. His role as the CMO involves ensuring that our efforts are properly aligned and optimizing exposure for Cardano and Project Catalyst. With his expertise, he will effectively promote the project's objectives and impact.
4. Ignacia Muñoz (CDO) - LinkedIn: Ignacia Muñoz Ignacia holds a degree in business engineering and administrarion, and possesses strong experience in digital marketing and blockchain technology. As the CDO, she focuses on maintaining an engaging online presence, leveraging digital media platforms to redirect attention to Cardano and Project Catalyst. She ensures that the project's activities are presented in an entertaining and captivating manner.

We have engaged with our team members and have direct lines of communication established to facilitate collaboration and coordination. We have also reached out to the relevant organizations and resources, such as the partnering research center and local government authorities, to discuss their support and involvement in the project. The necessary steps have been taken to ensure their willingness and capacity to contribute to the project's success.

How does the cost of the project represent value for money for the Cardano ecosystem?

The cost of the project represents value for money for the Cardano ecosystem for several reasons. Firstly, the budget allocation aligns with the specific milestones and activities outlined in the proposal, ensuring that the funds are directed towards achieving the project's objectives effectively.

The costs described in the proposal have been carefully determined based on various factors. For instance, the salaries or external consultant fees have been estimated considering the average wages in the relevant fields and industry standards. This ensures that the project team members are compensated fairly for their expertise and efforts. Additionally, market analysis for machinery and equipment costs have been included to ensure that the project acquires high-quality and efficient resources, contributing to long-term sustainability and productivity.

Moreover, the costs associated with live events, media coverage, branding, and marketing activities are essential for promoting the project's outcomes and raising awareness within the Cardano ecosystem. These expenses enable effective communication of the project's goals, attract stakeholders' attention, and create a positive impact. The allocation for community engagement, social media campaigns, and general project management ensures that the project remains connected with the Cardano community and operates smoothly throughout its duration.

By demonstrating a comprehensive budget, the proposal shows a responsible and transparent approach to financial planning. It ensures that the allocated funds are utilized efficiently and effectively towards achieving the project's milestones and goals. The budget aligns with industry standards, market analysis, and the specific requirements of the project, ensuring that the costs are justified and represent value for money.

Overall, the budget reflects a balanced approach that optimizes resources, leverages expertise, and ensures accountability. This approach maximizes the chances of the project delivering meaningful outcomes and providing value to the Cardano ecosystem, ultimately contributing to the long-term growth and success of the platform.